A股收評:三大指數升跌不一 旅遊酒店、中藥板塊午後衝高
A股主要指數午後小幅震盪,滬指翻紅,截至收盤,滬指升0.17%報2967點,深證成指跌0.75%,創業板指跌1.14%。兩市超3100股下跌,全天成交7375億元,北上資金淨買入16.89億元。盤面上,中泰兩國將從3月起永久互免對方公民簽證,旅遊酒店板塊午後延續強勢,長白山、大連聖亞升停;煤炭板塊走高,雲煤能源升停;2023年醫保目錄已正式執行,部分中藥注射劑品種的臨牀使用場景有望逐步拓寬,中藥板塊震盪走強,華森製藥升停;磷化工、遊戲及公用事業等板塊走高。另外,3D攝像頭板塊下挫,中光學、五方光電跌停;混合現實板塊走低,雙象股份跌停;機器人執行器板塊走弱,五洲新春領跌;MLCC、PEEK材料等板塊跌幅居前。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.